Anatara Lifesciences

(ASX) ANR

Current Price$0.01

Market Cap$2.84M

Since IPO (2014)-98%

5 Year-95%

1 Year+80%

1 Month+0%

Anatara Lifesciences Financials at a Glance

Market Cap

$2.84M

Revenue (TTM)

$473.61K

Net Income (TTM)

$2.84M

EPS (TTM)

$-0.01

P/E Ratio

-1.55

Dividend

$0.00

Beta (Volatility)

-0.43 (Low)

Dividend

$0.00

Beta (Volatility)

-0.43 (Low)

Price

$0.01

Volume

3,648,383

Open

$0.01

Price

$0.01

Volume

3,648,383

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.02

Dividend

$0.00

Beta (Volatility)

-0.43 (Low)

Price

$0.01

Volume

3,648,383

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.00 - $0.02

ANR News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Anatara Lifesciences

Industry

Biotechnology

Sector

Health Care

CEO

David Lionel Brookes, PhD

Website

anataralifesciences.com

Headquarters

Adelaide, VIC 3053, AU

ANR Financials

Key Financial Metrics (TTM)

Gross Margin

-55%

Operating Margin

-5%

Net Income Margin

-4%

Return on Equity

-105%

Return on Capital

-95%

Return on Assets

-69%

Earnings Yield

-64.52%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.84M

Shares Outstanding

315.95M

Volume

3.65M

Avg. Volume

329.42K

Financials (TTM)

Gross Profit

$633.97K

Operating Income

$1.96M

EBITDA

$1.96M

Operating Cash Flow

$2.27M

Capital Expenditure

$3.00

Free Cash Flow

$2.27M

Cash & ST Invst.

$101.36K

Total Debt

$407.42K

Anatara Lifesciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$84.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$2.84M

N/A

Market Cap/Employee

$406.23K

N/A

Employees

N/A

Net Income

$514.97K

+24.2%

EBITDA

$690.34K

+25.9%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Net Cash

$1.09M

+0.1%

Accounts Receivable

$206.12K

-29.5%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-68.76%

N/A

Return on Invested Capital

-95.47%

N/A

Free Cash Flow

$282.05K

+197.6%

Operating Cash Flow

$282.05K

+197.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

1AD.AXAdAlta Limited

1AD.AXAdAlta Limited$0.01+0.00%

OAK.AXOakridge International Limited

OAK.AXOakridge International Limited$0.09+4.44%

CTQ.AXCareteq Limited

CTQ.AXCareteq Limited$0.01-7.14%

OSX.AXOsteopore Limited

OSX.AXOsteopore Limited$0.01+0.00%

IBX.AXImagion Biosystems Limited

IBX.AXImagion Biosystems Limited$0.02+21.43%

EXL.AXElixinol Wellness Limited

EXL.AXElixinol Wellness Limited$0.01+0.00%

ACR.AXAcrux Limited

ACR.AXAcrux Limited$0.01+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

RIVNRivian Automotive

RIVNRivian Automotive$15.02-0.08%

Questions About ANR

What is the current price of Anatara Lifesciences?

Anatara Lifesciences is trading at A$0.01 per share.

What is the 52-week range for Anatara Lifesciences?

Over the past 52 weeks, Anatara Lifesciences has traded between A$0.00 and A$0.02.

How much debt does Anatara Lifesciences have?

As of the most recent reporting period, Anatara Lifesciences reported total debt of $407,420.

How much cash does Anatara Lifesciences have on hand?

Anatara Lifesciences reported $101,356 in cash and cash equivalents in its most recent financial results.

What is Anatara Lifesciences’s dividend yield?

Anatara Lifesciences does not currently have a dividend yield.

Anatara Lifesciences

Anatara Lifesciences Financials at a Glance

ANR News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Anatara Lifesciences

ANR Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Anatara Lifesciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ANR

What is the current price of Anatara Lifesciences?

What is the 52-week range for Anatara Lifesciences?

How much debt does Anatara Lifesciences have?

How much cash does Anatara Lifesciences have on hand?

What is Anatara Lifesciences’s dividend yield?

Premium Investing Services